Study of Healthy Aging and Physical Function With Elamipretide

NCT07275424 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Aging, Healthy

Interventions

DRUG: Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol)

Sponsor

David Marcinek

Collaborators

[object Object]